Increased Reflux Esophagitis after Helicobacter pylori Eradication Therapy in Cases Undergoing Endoscopic Submucosal Dissection for Early Gastric Cancer.
Masaki KatsuraharaIchiro ImotoYuhei UmedaHiroshi MiuraJunya TsuboiReiko YamadaTaro YasumaMisaki NakamuraYasuhiko HamadaHiroyuki InoueKyosuke TanakaNoriyuki HorikiEsteban C GabazzaYoshiyuki TakeiPublished in: Cancers (2021)
This study demonstrated that a successful H. pylori eradication therapy is a risk factor for newly developed reflux esophagitis in patients with endoscopic submucosal dissection for early gastric cancer.